RAC1 and diabetic kidney disease: To investigate whether RAC1 mediated renal ox-LDL deposition in DKD, we initially conducted IF staining and observed significantly higher levels of RAC1 in glomerulus, including podocytes, from DKD patients compared to those from HC (Fig. 3B).